In 2013 , in addition to the existing vaccine against avian influenza ( strain H5N1 ) , Microgen initiated the development of pre-pandemic " Chinese flu " vaccine ( strain H7N9 ) . Peter Kanygin , formerly Head of a Rostec structure , was appointed as the director-general of the company . The association 's net income has reached 1 bln . rubel
Chinese flu
Influenza A virus subtype H7N9
Microgen